While the level of cancer in the West, and globally, is taken up because of the lifestyle and environmental pollution, as well as the need for nuclear isotopes used in the detection of those cancers in a medical environment. But with many reactors built in the 1970s and 80s planned for closure, the materials used are becoming rarer and more expensive. Now, a start from Bristol, in the UK hopes to increase the production of these materials using a new, radical technology.
Astral Systems, bound by Talmon Firestone and Dr. Tom Wallce-Smith uses something called Multistate Fusion Technology (MSF) in its ‘compact reactors’, enabling the increased supply of nuclear isotopes used in modern medicine. These reactors are actually as compact as they can fit on the average table.
Astral has now closed over 4.5 million investments led by Austria -based VC Speedinvest and Playfair -based Playfair.
The company says its access will commercialize MSF technology, achieving better performance with greater efficiency and lower costs than traditional reactors.
The approach uses the so -called Fusion Fusion Fusion (LCF), a concept first discovered by NASA. This can achieve fuel density with solid state 400 million times higher than those of the company, according to the company.
Using previous research by NASA, Astral also claims that its platform can lead to other applications such as hybrid nuclear energy, spatial exploration and industrial and security industry applications.
Astral and CTO co-founder, Dr. Tom Wallace-Smith told Techcrunch: “The whole industry has been in restriction of supply historically because of this belief in centralized reactors.”
“While what we are proposing are putting them in industrial units or in the basement of hospitals or production centers. We can then produce medicines exactly where they needed, and be able to reduce confidence in these centralized countries production, ”he added.
He believes competitors are limited by existing technology: “Most other approaches are based on linear, accelerated technology, while what we are doing is essentially taking an essential TRL architecture and the placement of physics in 2020, where the ceiling It is quite high in terms of performance.
In a statement, Rick Hao, partner in Speedinvest, added: “Astral Systems represents the best of Deeptech in the UK. Astral is providing a fresh approach to nuclear melting that addresses urgent medical, industrial and energy needs.”
So far Astral has created three merger trade facilities from which it is already generating income.
Also participation in the round was the participation of angel investors, including Oliver Buck, the founder of ITM Izotope Technologies and the former president of the product of products, Pete Hutton.
